Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
Open Access
- 15 June 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 13 (1), 103
- https://doi.org/10.1186/1471-2474-13-103
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The geoepidemiology of autoimmune muscle diseaseAutoimmunity Reviews, 2010
- Dermatomyositis and polymyositisAnnals of the New York Academy of Sciences, 2010
- Incidence of Dermatomyositis and Clinically Amyopathic DermatomyositisArchives of Dermatology, 2010
- Inclusion body myositis: old and new conceptsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Evaluation and treatment of inflammatory myopathiesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Treatment of the inflammatory myopathies: update and practical recommendationsExpert Opinion on Pharmacotherapy, 2009
- Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differencesAnnals Of The Rheumatic Diseases, 2008
- Update on idiopathic inflammatory myopathiesAutoimmunity, 2006
- 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The NetherlandsNeuromuscular Disorders, 2004
- Myositis as a Cause of Muscle PainJournal of Musculoskeletal Pain, 1999